Lymphoproliferative response to HIV type 1 p24 in long-term survivors of HIV type I infection is predictive of persistent AIDS-free infection

被引:54
作者
Pontesilli, O
Carotenuto, P
Kerkhof-Garde, SR
Roos, MTM
Keet, IPM
Coutinho, RA
Goudsmit, J
Miedema, F
机构
[1] CLB Sanquin Blood Supply Fdn, Dept Clin Viroimmunol, NL-1066 CX Amsterdam, Netherlands
[2] Univ Amsterdam, Acad Med Ctr, Clin & Expt Immunol Lab, NL-1066 CX Amsterdam, Netherlands
[3] Univ Amsterdam, Acad Med Ctr, Dept Human Retroviol, NL-1105 AZ Amsterdam, Netherlands
[4] Municipal Hlth Serv, Div Publ Hlth & Environm, NL-1011 HW Amsterdam, Netherlands
关键词
D O I
10.1089/088922299310485
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
To establish immunologic correlates of progression to AIDS in long-term survivors of HDV-1 infection, HIV-1-specific T cell-mediated responses, together with T cell reactivity to recall antigens, were studied in frozen samples collected after 5 and 8 years of documented HIV-1 infection. Eight of 21 homosexual men, who remained asymptomatic and maintained CD4(+) T cell numbers >400 cells/mu l for 9 years of HIV-1 infection, progressed to AIDS (CDC 1993 definition) within 12.5 years of infection (late progressors, LPs). The remainders showed minimal deterioration of immune parameters (long-term nonprogressors, LTNPs). CD4(+) T cell numbers and T cell function measured at years 5 and 8 of follow-up were comparable in the two groups. At both time points responses to recall antigens did not significantly differ between the two groups, although a significant decline of lymphoproliferative responses to Candida and tetanus toroid was observed in Lps. Circulating HIV-1-specific cytotoxic T lymphocyte precursors were found in broad frequency ranges in both Ups and LTNPs and, similarly, no significant differences were found in comparing the breadth of serum neutralizing activity against heterologous HIV-1 primary isolates. In contrast, lymphoproliferative responses to p24(gag), but not p17(gag) or gp160(env), were detected only in LTNPs and were totally absent in LPs at both time points (p < 0.01). Our data suggest that the presence of circulating p24-specific CD4(+) T cells may reflect effective viral control and be predictive of subsequent favorable clinical course in long-term asymptomatic individuals.
引用
收藏
页码:973 / 981
页数:9
相关论文
共 45 条
[21]   KINETICS OF GAG-SPECIFIC CYTOTOXIC T-LYMPHOCYTE RESPONSES DURING THE CLINICAL COURSE OF HIV-1 INFECTION - A LONGITUDINAL ANALYSIS OF RAPID PROGRESSORS AND LONG-TERM ASYMPTOMATICS [J].
KLEIN, MR ;
VANBAALEN, CA ;
HOLWERDA, AM ;
KERKHOFGARDE, SR ;
BENDE, RJ ;
KEET, IPM ;
EEFTINCKSCHATTENKERK, JKM ;
OSTERHAUS, ADME ;
SCHUITEMAKER, H ;
MIEDEMA, F .
JOURNAL OF EXPERIMENTAL MEDICINE, 1995, 181 (04) :1365-1372
[22]   Gag-specific immune responses after immunization with p17/p24:Ty virus-like particles in HIV type 1-seropositive individuals [J].
Klein, MR ;
Veenstra, J ;
Holwerda, AM ;
Roos, MTL ;
Gow, I ;
Patou, G ;
Coutinho, RA ;
DeWolf, F ;
Miedema, F .
AIDS RESEARCH AND HUMAN RETROVIRUSES, 1997, 13 (05) :393-399
[23]   LONG-TERM SURVIVORS OF HIV-1 INFECTION [J].
KLEIN, MR ;
MIEDEMA, F .
TRENDS IN MICROBIOLOGY, 1995, 3 (10) :386-391
[24]   LYMPHOCYTE PROLIFERATIVE RESPONSES TO HUMAN IMMUNODEFICIENCY VIRUS-ANTIGENS INVITRO [J].
KROWKA, JF ;
STITES, DP ;
JAIN, S ;
STEIMER, KS ;
GEORGENASCIMENTO, C ;
GYENES, A ;
BARR, PJ ;
HOLLANDER, H ;
MOSS, AR ;
HOMSY, JM ;
LEVY, JA ;
ABRAMS, DI .
JOURNAL OF CLINICAL INVESTIGATION, 1989, 83 (04) :1198-1203
[25]  
LAMHAMEDICHERRADI S, 1995, AIDS, V9, P421, DOI 10.1097/00002030-199509050-00002
[26]   THE NATURAL-HISTORY OF HUMAN IMMUNODEFICIENCY VIRUS-INFECTION [J].
LIFSON, AR ;
RUTHERFORD, GW ;
JAFFE, HW .
JOURNAL OF INFECTIOUS DISEASES, 1988, 158 (06) :1360-1367
[27]   CD4(+) T-CELLS ARE REQUIRED TO SUSTAIN CD8(+) CYTOTOXIC T-CELL RESPONSES DURING CHRONIC VIRAL-INFECTION [J].
MATLOUBIAN, M ;
CONCEPCION, RJ ;
AHMED, R .
JOURNAL OF VIROLOGY, 1994, 68 (12) :8056-8063
[28]   QUANTITATION OF HIV-1 RNA IN PLASMA PREDICTS OUTCOME AFTER SEROCONVERSION [J].
MELLORS, JW ;
KINGSLEY, LA ;
RINALDO, CR ;
TODD, JA ;
HOO, BS ;
KOKKA, RP ;
GUPTA, P .
ANNALS OF INTERNAL MEDICINE, 1995, 122 (08) :573-579
[29]   Early protective effect of CCR-5 Delta 32 heterozygosity on HIV-1 disease progression: relationship with viral load [J].
Meyer, L ;
Magierowska, M ;
Hubert, JB ;
Rouzioux, C ;
Deveau, C ;
Sanson, F ;
Debre, P ;
Delfraissy, JF ;
Theodorou, I ;
Bary, M ;
Burgard, M ;
Dormont, J ;
Boue, F ;
Levy, A ;
Dellamonica, P ;
Perbost, I ;
Carles, M ;
Mondain, V ;
Guillevin, L ;
Jarousse, B ;
Trogoff, B ;
Lebras, P ;
Goujard, C ;
Quertainmont, Y ;
Vilde, JL ;
Leport, C ;
Colassante, U ;
Kazatchkine, M ;
Vellay, A ;
Buisson, M ;
Cassuto, JP ;
Reboulot, B ;
Quaranta, M ;
Sereni, D ;
Gomez, V ;
Bachmeyer, C ;
Gallais, H ;
Mars, ME ;
Gallais, J ;
Sobel, A ;
Duval, J ;
Majerhole, C ;
Deforges, L ;
Lefrere, JJ ;
Lerable, J ;
Joubert, L ;
Dupont, B ;
Beuzelin, C ;
Fournier, S ;
Vittecoq, D .
AIDS, 1997, 11 (11) :F73-F78
[30]   Frequency of HLA allele-specific peptide motifs in HIV-1 proteins correlates with the allele's association with relative rates of disease progression after HIV-1 infection [J].
Nelson, GW ;
Kaslow, R ;
Mann, DL .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1997, 94 (18) :9802-9807